Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,540.00    -20.00 (-0.36%)
Bid:
5,570.00
Ask:
5,580.00
Spread: 10.00 (0.18%)
Market Cap: £2.97b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Fourth quarter trading statement

4 Apr 2011 07:00

RNS Number : 1909E
Cranswick PLC
04 April 2011
 

4 April 2011

Cranswick plc

("Cranswick" or "the Company")

 

Fourth quarter trading statement

 

Current trading

 

The Board anticipates that the Company's trading performance for the year to 31 March 2011 will be broadly in line with its expectations. The results are expected to be released on 16 May 2011.

 

Underlying, like-for-like sales for the year to 31 March 2011 increased by 4 per cent. Volumes were ahead by 6 per cent on the same basis. In the fourth quarter underlying sales were in line with those of the previous year. The Deeside cooked meat business was transferred into the Farmers Boy (Deeside) Limited joint venture on 9 July 2010 and from this date onwards sales are excluded from Group total sales. This impacts the comparison of total sales which for the full year were 2 per cent ahead of last year and in the fourth quarter were 6 per cent lower.

 

Operating margin was in line with management's expectations.

 

Following the successful commissioning of the new abattoir at the Company's fresh pork facility in Hull and investment to deliver improved operating efficiencies at the Norfolk facility, the Company's fresh pork activities are now fully integrated. The capital expenditure and commissioning of the project at the bacon factory is now substantially complete.

 

Financial position

 

Cash generation from operating activities has remained strong through the final quarter, resulting in year-end net debt being lower than that of a year ago. The Company has put in place a new four year bank facility, on improved terms, which provides appropriate headroom going forward.

 

Outlook

 

The difficulties facing the UK consumer and the dynamics of the competitive UK market in which the Company operates suggests the year to 31 March 2012 may be more demanding than usual. However, the Board anticipates that with the Company's well invested asset base, strong range of products, experienced management team and robust financial position, it is well positioned to continue the long-term development of the Company.

 

 

Enquiries:

Paul Quade 07947 186694

CityRoad Communications 020 7248 8010

 

Notes:

 

1. Cranswick's activities are focused within the UK and include the processing and supply of fresh pork, sausage, bacon, cooked meats, charcuterie and sandwiches. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2010 showed sales of £740m and profit before tax of £43.8m.

2. This announcement is based on information sourced from unaudited management accounts.

3. This announcement contains certain forward looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward looking statements. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDFLFBFZFZBBK
Date   Source Headline
11th Mar 20257:05 amRNSDirectorship
5th Mar 20252:24 pmRNSTotal Voting Rights
3rd Mar 20253:27 pmRNSHolding(s) in Company
24th Feb 20254:54 pmRNSDirector/PDMR Shareholding
10th Feb 20252:51 pmRNSAdditional Listing
3rd Feb 202510:04 amRNSTotal Voting Rights
22nd Jan 20251:21 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSQ3 Trading Update and Acquisition of JSR Genetics
7th Jan 20254:02 pmRNSTotal Voting Rights
27th Dec 20247:00 amRNSDirector/PDMR Shareholding
11th Dec 20243:26 pmRNSHolding(s) in Company
3rd Dec 20249:53 amRNSTotal Voting Rights
26th Nov 20247:00 amRNSINTERIM RESULTS
13th Nov 202411:41 amRNSTotal Voting Rights
1st Oct 202412:46 pmRNSTotal Voting Rights
1st Oct 202412:43 pmRNSBlock Listing LTIP return
1st Oct 202412:41 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 202412:38 pmRNSDirector/PDMR Shareholding
27th Sep 20247:00 amRNSHalf Year Trading Update
25th Sep 20243:19 pmRNSDirector/PDMR Shareholding
16th Sep 202411:56 amRNSHolding(s) in Company
16th Sep 202411:55 amRNSHolding(s) in Company
12th Aug 202412:15 pmRNSDirector/PDMR Shareholding
6th Aug 20244:20 pmRNSDirector/PDMR Shareholding
5th Aug 202412:18 pmRNSDirector/PDMR Shareholding
5th Aug 202412:16 pmRNSDirector/PDMR Shareholding
5th Aug 202412:15 pmRNSDirector/PDMR Shareholding
5th Aug 202412:11 pmRNSDirector/PDMR Shareholding
1st Aug 202410:52 amRNSTotal Voting Rights
29th Jul 20244:02 pmRNSAGM Statement
29th Jul 20247:00 amRNSFirst quarter trading statement
3rd Jun 20249:42 amRNSTotal Voting Rights
21st May 20247:00 amRNSPreliminary Results
15th May 20245:22 pmRNSDirector/PDMR Shareholding
2nd May 20249:26 amRNSTotal Voting Rights
2nd Apr 20241:55 pmRNSBlock listing Interim Review
2nd Apr 20241:54 pmRNSBlock listing Interim Review
2nd Apr 20241:50 pmRNSTotal Voting Rights
27th Mar 20249:58 amRNSDirector/PDMR Shareholding
21st Mar 20241:57 pmRNSDirector/PDMR Shareholding
21st Mar 20241:55 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirectorate Change
15th Mar 20243:58 pmRNSDirector/PDMR Shareholding
4th Mar 20249:58 amRNSTotal Voting Rights
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
2nd Feb 202411:00 amRNSTotal Voting Rights
18th Jan 20247:00 amRNSThird quarter trading statement
3rd Jan 20247:00 amRNSDirector/PDMR Shareholding
2nd Jan 20243:05 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.